Epogen Side Effects
UPDATE (5/21/2007): The lawyers at Saiontz, Kirk & Miles, P.A. are no longer reviewing or considering Epogen lawsuits on behalf of users who suffered from drugs side effects. >>READ WHY
Individuals who are given Procrit injections at high doses could face an increased risk of serious and potentially fatal injuries as a result of Procrit side effects.
Epogen Injection Problems
Procrit (generic name epoetin alfa) is commonly used for treatment of anemia, especially following dialysis or chemotherapy. Studies have demonstrated that serious injuries could be caused by the use of the injection, especially when it is administered at high doses.
As a result of Procrit side effects, individuals face an increase risk of the following injuries:
- Heart attack
- Stroke
- Blood Clots
- Pulmonary Embolism
- Deep Vein Thrombosis
- Rapid Growth of Pre-Existing Tumors
- Death
>>INFORMATION: Procrit Anemia Injection Side Effects
PROCRIT INJECTIONS
Procrit was approved on June 1, 1989 for treatment of anemia which occurs in those with kidney failure, cancer patients where anemia is caused by chemotherapy, HIV patients taking AZT (zidovudine) and before some major surgeries. In the United States, it is marketed and distributed by Ortho Biotech, LP, a subsidiary of the pharmaceutical giant, Johnson & Johnson.
Procrit is one of three medications in a class of drugs known as erythropoiesis stimulating agents (ESA). The other two drugs are Aranesp and Epogen, both manufacturered and marketed by Amgen, Inc. The combined U.S. sales of all three drugs in this class are approximately $10 billion each year, with Procrit accounting for approximately $2 billion.
All three ESA amenia injections work the same way, so Aranesp side effects and Procrit side effects could result in the same problems as Procrit. In March 2007, the FDA required that all three anemia injections contain a warning about the dangers of using the drugs at high doses for aggressive treatment of anemia.
